ClinicalTrials.gg
Not yet recruitingNCT07941193Updated Nov 17, 2026

Effectiveness of a Standardized Healthcare Education Program in People With Heart Failure

An interventional study of Visit with specialist nurse with structured interview, application of scales and educational intervention in Heart Failure and Nurse Led Intervention, sponsored by Fundacio Salut Emporda. Not yet recruiting. Open to participants aged 18 Years to 110 Years. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by Fundacio Salut Emporda · Not applicable, Interventional, and Prevention

Updated Nov 17, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
180
Allocation
Randomized
Ages
18 Years to 110 Years
Sex
All
01

Study summary

Heart failure is a chronic illness with a high prevalence and impact on the quality of life of the people who experience it, associated with high hospital taxes and mortality. Beyond the results of traditional clinics, factors such as health literacy, therapeutic adherence and self-healing play a key role in the evolution of this pathology. Various studies show that inadequate health literacy levels lead to better control of malaria, more re-entry and a lower quality of life.

The objective of this research is to evaluate the effectiveness of a standard health education care program, led by nurses specialized in heart failure, initiating discharge from hospitals and with structured follow-up during the first few months afterward, compared to conventional care. It is intended to analyze its impact on health literacy, therapeutic adherence, self-healing, and quality of life, as well as explore the associated social determinants.

It will last a random clinical trial between two groups (intervention and control) at the Heart Failure Unit of the Figueres Hospital. The participants will be adults admitted for decompensation of heart failure and will be followed for 12 months, with evaluations at admission, at 6 months and at any time after discharge. It is important to serve validated instruments to measure quality of life, health literacy and therapeutic adherence.

It is hoped that the intervention will improve the quality of life and health literacy of people with heart failure, contributing to more equitable care, centered on the person and oriented towards better health outcomes.

02

Conditions studied

  • Heart Failure
  • Nurse Led Intervention

Browse trials for

Keywords

  • Heart Failure
  • Nursing
  • Nurse Led Intervention
  • Quality of Life
03

In context

Heart Failure

6,334 studies on the registry are indexed under Heart Failure; 1,394 are open to participants now.

This study's planned enrollment of 180 is above the median of 76 across 4,049 interventional studies indexed under Heart Failure.

Browse Heart Failure studies →

Lead sponsor

This is the only study on the registry with Fundacio Salut Emporda as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 110 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • People who are admitted for decompensated heart failure, and who are going to undergo post-discharge monitoring at the Heart Failure Unit of the Figueres Hospital.
  • have signed the .

Exclusion criteria

Exclusion Criteria:

  • People diagnosed with cognitive impairment or dementia.
  • Institutionalized people.
  • Foreign people or people who live outside the hospital's reference area.
  • People with language difficulties.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
180 participants (estimated)

Study arms

  • Experimental
    Educational group

    In the case of the intervention group, a standardized, structured and more intense follow-up plan than usual will be applied.

    Behavioral: Visit with specialist nurse with structured interview, application of scales and educational intervention

  • No intervention
    control group

    usual nursing care

Interventions

  • BehavioralVisit with specialist nurse with structured interview, application of scales and educational intervention

    This next step will begin after discharge from the hospital with a face-to-face visit from specialized nursing, in which a comprehensive assessment will be carried out, the administration of measurement scales, individualized health education and coordination of primary care and other assistance devices if necessary.

06

What researchers measure

Primary outcomes

  1. Number of patients with nursing intervention who need hospital admission in a year

    Review of the patient's medical history at the annual visit to see how many times they have been admitted for heart failure decompensation. The number of admissions, the main admission diagnosis, and the number of days in the hospital will be reviewed

    Time frame: From enrollment to the end of treatment at 12 months

  2. Number of visits to the emergency room in the past year for patients who have undergone the nursing intervention

    Review of the patient's medical history at the annual visit to see the number of emergency visits for heart failure decompensation. The number of visits to the emergency room, the reason for the visit, the main diagnosis at discharge, and the patient's destination will be checked

    Time frame: From enrollment to the end of treatment at 12 months

Secondary outcomes

  1. Number of people with a good level of self-care according to the scale Self-Care of Heart Failure Index who have received intervention from the nurse

    The questionnaire consists of 22 items spread across three independent scales that assess the patient's behaviors over the past month. The items are answered using a four-point Likert scale. The scores for each scale are calculated separately and converted into standardized values from 0 to 100, where higher scores indicate a better level of self-care. A score of 70 or above is considered indicative of adequate self-care.

    Time frame: From enrollment to the end of treatment at 12 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — It is a single-center study that does not intend to share information with third parties and will only publish the research results.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2027; primary completion for Jan 2029, 24 months later.

Of 1,118 non-industry interventional studies with no phase under Heart Failure, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 50. This study's planned 24 months is below that.

Counting every sponsor, half of 1,354 studies reached it within 31 months; a quarter within 16 and three quarters within 52.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 5, 2026
First posted
Nov 17, 2026
StartEst.
Jan 11, 2027
Primary completionEst.
Jan 2029
CompletionEst.
Jun 2029
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07941193
Lead sponsor
Fundacio Salut Emporda
Responsible party
Sponsor
First posted
Nov 17, 2026
Start date
Jan 11, 2027 (estimated)
Primary completion
Jan 2029 (estimated)
Completion
Jun 2029 (estimated)
Last update
Nov 17, 2026

Study contacts

Clara Vargas Farber, RN Nurse
Contact
cvargas@salutemporda.cat
+34972592005
Silvia Zuheros Santó, Administrative
Contact
szuheros@salutemporda.cat
Maria Rosa Suñer Soler, RN, PhD
study director · Universitat de Girona
Aurora Fontova Almató, RN, PhD
study chair · Fundacio Salut Emporda

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion